Cordis to distribute Medinol stents

Cordis Corp. said Wednesday it signed a definitive agreement to become the exclusive global distributor of a a family of bare metal stents for coronary applications developed by Jerusalem-based Medinol.

Cordis Corp. said Wednesday it signed a definitive agreement to become the exclusive global distributor of a a family of bare metal stents for coronary applications developed by Jerusalem-based Medinol. The two companies will work together to obtain approvals to market the products from US and other regulatory authorities. Cordis expects the stents to be available outside the US in the second half of this year and within the US in the second half of 2008.